Recursion Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Recursion Pharmaceuticals Total Assets Growth & History (RXRX)
Recursion Pharmaceuticals's total assets was $1.47B for fiscal 2025.
View full Recursion Pharmaceuticals company overviewRecursion Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.47B | $25.5M | +1.76% |
| 2024 | 2024-12-31 | $1.45B | $794.9M | +121.60% |
| 2023 | 2023-12-31 | $653.7M | −$47.6M | −6.79% |
| 2022 | 2022-12-31 | $701.3M | $90.9M | +14.90% |
| 2021 | 2021-12-31 | $610.3M | $311.8M | +104.41% |
| 2020 | 2020-12-31 | $298.6M | — | — |
Recursion Pharmaceuticals quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.21B | −$89.7M | −6.89% |
| Q1 2026 | 2026-03-31 | $1.34B | $34.3M | +2.63% |
| Q4 2025 | 2025-12-31 | $1.47B | $25.5M | +1.76% |
| Q3 2025 | 2025-09-30 | $1.40B | $673.0M | +92.64% |
| Q2 2025 | 2025-06-30 | $1.30B | $526.5M | +67.86% |
| Q1 2025 | 2025-03-31 | $1.31B | $747.4M | +133.98% |
| Q4 2024 | 2024-12-31 | $1.45B | $794.9M | +121.60% |
| Q3 2024 | 2024-09-30 | $726.5M | $95.7M | +15.17% |
| Q2 2024 | 2024-06-30 | $775.9M | $109.2M | +16.37% |
| Q1 2024 | 2024-03-31 | $557.8M | −$69.5M | −11.08% |
| Q4 2023 | 2023-12-31 | $653.7M | −$47.6M | −6.79% |
| Q3 2023 | 2023-09-30 | $630.8M | $19.3M | +3.15% |
| Q2 2023 | 2023-06-30 | $666.7M | −$5.8M | −0.86% |
| Q1 2023 | 2023-03-31 | $627.4M | −$107.0M | −14.56% |
| Q4 2022 | 2022-12-31 | $701.3M | $90.9M | +14.90% |
| Q3 2022 | 2022-09-30 | $611.5M | −$47.1M | −7.15% |
| Q2 2022 | 2022-06-30 | $672.5M | −$26.1M | −3.73% |
| Q1 2022 | 2022-03-31 | $734.3M | $462.4M | +170.03% |
| Q4 2021 | 2021-12-31 | $610.3M | $311.8M | +104.41% |
| Q3 2021 | 2021-09-30 | $658.6M | — | — |
| Q2 2021 | 2021-06-30 | $698.6M | — | — |
| Q1 2021 | 2021-03-31 | $271.9M | — | — |
| Q4 2020 | 2020-12-31 | $298.6M | — | — |
Recursion Pharmaceuticals total assets trends
Over the last five fiscal years, Recursion Pharmaceuticals's total assets increased from $298.6M to $1.47B, a change of $1.18B. The latest reported quarter, Q2 2026, shows $1.21B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Recursion Pharmaceuticals source filings ↗